{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:41:40Z","timestamp":1793065300777,"version":"4.5.0"},"reference-count":30,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The European Journal of Contraception & Reproductive Health Care"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.3109\/13625187.2013.785516","type":"journal-article","created":{"date-parts":[[2013,5,2]],"date-time":"2013-05-02T21:03:55Z","timestamp":1367528635000},"page":"274-283","source":"Crossref","is-referenced-by-count":15,"title":["Hormone withdrawal-associated symptoms: Comparison of oestradiol valerate\/dienogest versus ethinylestradiol\/norgestimate"],"prefix":"10.1080","volume":"18","author":[{"given":"Jeffrey T.","family":"Jensen","sequence":"first","affiliation":[{"name":"*Department of Obstetrics & Gynecology, Oregon Health & Science University,\rPortland, Oregon, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Parke","sequence":"additional","affiliation":[{"name":"Global Clinical Development Women's Healthcare, Bayer HealthCare Pharmaceuticals,\rBerlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Mellinger","sequence":"additional","affiliation":[{"name":"Global Clinical Statistics, Bayer HealthCare Pharmaceuticals,\rBerlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Serrani","sequence":"additional","affiliation":[{"name":"Global Medical Affairs Women's HealthCare, Bayer HealthCare Pharmaceuticals,\rBerlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"R. Garn","family":"Mabey","sequence":"additional","affiliation":[{"name":"MountainView Hospital,\rLas Vegas, Nevada, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2013,5,2]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(99)00524-4"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000233888.18228.19"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000249114.52802.55"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(04)00768-9"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2012.651931"},{"key":"e_1_3_2_7_1","first-page":"9","volume-title":"Cephalalgia","author":"Headache Classification Subcommittee of the International Headache Society","year":"2004","unstructured":"Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd edn. Cephalalgia 2004;24 (Suppl. 1):9\u2013160.","edition":"2"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-011-0538-z"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-009-0051-9"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(96)00137-0"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2007.00650.x"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(96)00488-7"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/13625180902850039"},{"issue":"1","key":"e_1_3_2_14_1","first-page":"S100","article-title":"Hormone withdrawal-associated symptoms (headache and pelvic pain) in women taking combined oral contraceptives: Comparison of oestradiol valerate\/dienogest versus ethinylestradiol\/levonorgestrel","volume":"17","author":"Merki-Feld G","year":"2012","unstructured":"Merki-Feld G, Macias G, Parke S, et al. Hormone withdrawal-associated symptoms (headache and pelvic pain) in women taking combined oral contraceptives: Comparison of oestradiol valerate\/dienogest versus ethinylestradiol\/levonorgestrel. Eur J Contracept Reprod Health Care 2012;17 (Suppl. 1):S100.","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.12.089"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1990.1006305.x"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.6.1076"},{"issue":"3","key":"e_1_3_2_18_1","first-page":"143","article-title":"Migraine associated with menstruation","volume":"15","author":"MacGregor A","year":"2000","unstructured":"MacGregor A. Migraine associated with menstruation. Funct Neurol 2000;15(Suppl. 3):143\u201353.","journal-title":"Funct Neurol"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.20191"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1701-2163(16)30395-4"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2008.02.019"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2012.01.018"},{"key":"e_1_3_2_23_1","unstructured":"Ortho Tri-Cyclen \u00ae Lo Full Prescribing Information. Accessed 7 February 2013 from: http:\/\/www.myortho360.com\/sites\/default\/files\/assets\/Tri-Cyclen_Lo_PI.pdf#zoom=100"},{"key":"e_1_3_2_24_1","first-page":"33","volume-title":"Menopause \u2013 Andropause: Hormone replacement therapy through the ages: New cognition and therapy concepts","author":"Kuhl H","year":"2001","unstructured":"Kuhl H. Pharmacology of estrogens and gestagens. In: Fischl FH, ed. Menopause \u2013 Andropause: Hormone replacement therapy through the ages: New cognition and therapy concepts. Gablitz, Germany: Krause & Pachernegg GmbH 2001:33\u201350."},{"key":"e_1_3_2_25_1","first-page":"15","volume-title":"Handbook of pain assessment","author":"Jensen MP","year":"2001","unstructured":"Jensen MP, Karoly P. Self-report scales and procedures for assessing pain in adults. In: Turk DC & Melzack R, eds. Handbook of pain assessment. New York: Guilford Press 2001:15\u201334."},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1526-5900(03)00716-8"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(01)00371-2"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(96)70238-X"},{"key":"e_1_3_2_29_1","unstructured":"Moos R. Menstrual Distress Questionnaire (MDQ) \u2013 The standard method for measuring cyclical perimenstrual symptoms 4th edn. Accessed 5 July 2012 from: http:\/\/www.mindgarden.com\/products\/mdq.htm"},{"key":"e_1_3_2_30_1","first-page":"28","article-title":"The clinical global impressions scale: Applying a research tool in clinical practice","volume":"4","author":"Busner J","year":"2007","unstructured":"Busner J, Targum SD. The clinical global impressions scale: Applying a research tool in clinical practice. Psychiatry 2007;4:28\u201337.","journal-title":"Psychiatry"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:QURE.0000018499.64574.1f"}],"container-title":["The European Journal of Contraception & Reproductive Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/13625187.2013.785516","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T09:20:14Z","timestamp":1706865614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/13625187.2013.785516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,2]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["10.3109\/13625187.2013.785516"],"URL":"https:\/\/doi.org\/10.3109\/13625187.2013.785516","relation":{},"ISSN":["1362-5187","1473-0782"],"issn-type":[{"value":"1362-5187","type":"print"},{"value":"1473-0782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,2]]}}}